Half-times of irradiation recovery in accelerated partialbreast irradiation: Incomplete recovery as a potentially dangerous enhancer of radiation damage
Journal Title: Journal of Cancer Research & Therapy - Year 2013, Vol 1, Issue 10
Abstract
Purpose: To compare clinical results from accelerated partial breast irradiation with predictions from different half-times of recovery of radiation damage. Method: Three published results of excessive late complications led to an editorial which was a “wake up call” to the possible hazards of fractions spaced close together such as two fractions of 3.85 Gy a day on five consecutive days. These results are re-examined here using linear quadratic modelling with mono-exponential and bi-exponential recovery kinetics. Results: Although clinical results showed rather high proportions of severe complications, only in one of the three studies discussed in reference [1] complications were severe enough to cause it to be terminated. Since then other studies with the same doses have reported acceptable results. However, none of these complication rates are predicted to be tolerable, if mono-exponential kinetics with a single T ½ of ~4 hours is assumed. Conclusions: Better matches to clinical results can be found by assuming bi-exponential recovery with 50%-50% components of 0.3 hand 4 h, and α/β = 3 Gy, for late complications. There is continuing need for data from more clinical results, especially concerning various tumour types.
Authors and Affiliations
Fowler JF
Keywords
Related Articles
- EP ID EP551838
- DOI 10.14312/2052-4994.2013-35
- Views 42
- Downloads 0
Total meso-esophagogastrectomy in surgically resectable Siewert type II-III junctional gastric cancer: Safety and long term oncologic outcome
Aim: To analyze our experience confronting meso-esophagogastric resection (transhiatally extended total gastrectomy en-bloc with its inviolate primitive dorsal and ventral mesenterium) to less radical planes of surgery (...
Synergistic antineoplastic action of 5-aza-2'deoxycytidine (decitabine) in combination with different inhibitors of enhancer of zeste homolog 2 (EZH2) on human lung carcinoma cells
Patients with metastatic lung cancer have a very poor prognosis indicating an urgent need to develop more effective chemotherapy. Aberrant promoter DNA methylation can result in the epigenetic silencing of tumor suppress...
Changing clinical picture of endemic Burkitt’s lymphoma with improved diagnostic technology: A systematic review
We evaluated the changes in anatomical locations of endemic Burkitt’s lymphoma (eBL) by systematic review. We compared the reports before ultrasound became a routine investigation in Burkitt’s lymphoma (BL) diagnosis wit...
Development of a new formulation of interferons (HEBERPAG) for BCC treatment
Purpose: This work is aimed to show briefly, the clinical development of a new pharmaceutical formulation of interferons for the treatment of basal cell carcinoma. Methods: A rationale design of the combination of IFN-α2...
Characterizing tobacco use in an American cancer center’s catchment area can help direct future research priorities
Purpose: American cancer centers supported by the National Cancer Institute (NCI) must ensure that their research addresses the cancer relevant needs and risks of members of their catchment area. In 2016, the NCI support...